Global Neurology Radiopharma Product Leader

Role: Global Neurology Radiopharma Product Leader responsible for defining and executing the strategy for the neurology molecular imaging portfolio, focusing on Parkinson’s and Alzheimer’s diseases. Core responsibilities include developing target product profiles, shaping indication strategies, leading evidence generation plans, managing product lifecycle from pre-launch to post-market, and driving market expansion globally, especially in the U.S. The role requires cross-functional collaboration with R&D, Medical Affairs, Regulatory, Market Access, and Commercial teams to support pipeline advancement, launch, and lifecycle management. High-value specifics include expertise in PET/SPECT radiopharmaceuticals, neurology (particularly Alzheimer’s and Parkinson’s), and experience in diagnostic imaging product leadership. The candidate should have an advanced degree (PhD, MD, PharmD), significant experience in product development and lifecycle management, and established relationships within the neurology and neuroimaging community. Prior experience with U.S. product launches and a strong strategic/clinical background in molecular imaging are preferred. The role involves global market insights, portfolio prioritization, and external stakeholder engagement. Work setup details are not specified, but the position is based in the U.S. with no relocation assistance provided.